CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Aggressive Measures to Decrease Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction High-Sensitivity Troponins and Outcomes After Myocardial Infarction Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults Management of Acute Myocardial Infarction During the COVID-19 Pandemic Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front

Clinical Trial26 Sep 2019

JOURNAL:Circulation. Article Link

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

S Windecker , RD Lopes, AUGUSTUS Investigators et al. Keywords: antithrombotic therapy; atrial fibrillation; ACS patients; safety and efficacy

FULL TEXT PDF